Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

X4 Pharmaceuticals, Inc

NASDAQ: XFOR · Life Sciences · 5 alerts · CIK 1501697

Share price
$2.83Close, Nov 16
Market cap
$289M
Shares outstanding
102.11MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All X4 Pharmaceuticals, Inc filings on SEC EDGAR ↗

5:23 PM ET 8-K
Loan & Debt

X4 Pharmaceuticals $150M Debt Financing with K2 HealthVentures LLC

X4 Pharmaceuticals entered into a $150 million senior secured term loan facility with K2 HealthVentures, consisting of an immediate $80 million tranche and an additional $70 million available upon request and lender approval. The proceeds were used to repay an existing $75 million loan from Hercules and will support the potential commercial launch of mavorixafor. The new facility features a 48-month maturity and an interest-only period through at least October 2029.

Value
$150M
Counterparty
K2 HealthVentures LLC
Term
4 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.